Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

Keith W Muir; Gary A Ford; Ian Ford; Joanna M Wardlaw; Alex McConnachie; Nicola Greenlaw; Grant Mair; Nikola Sprigg; Christopher I Price; Mary Joan MacLeod; Sofia Dima; Marius Venter; Liqun Zhang; Eoin O’brien; Ranjan Sanyal; John Reid; Laszlo k Sztriha; Syed Haider; William N Whiteley; James Kennedy; Richard Perry; Sekaran Lakshmanan; Annie Chakrabarti; Ahamad Hassan; Richard Marigold; Senthil Raghunathan; Don Sims; Mohit Bhandari; Ivan Wiggam; Khalid Rashed; Chris Douglass; ATTEST-2 Investigators

doi:10.1016/S1474-4422(24)00377-6

Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

Keith W Muir^*, Gary A Ford, Ian Ford, Joanna M Wardlaw, Alex McConnachie, Nicola Greenlaw, Grant Mair, Nikola Sprigg, Christopher I Price, Mary Joan MacLeod, Sofia Dima, Marius Venter, Liqun Zhang, Eoin O’brien, Ranjan Sanyal, John Reid, Laszlo k Sztriha, Syed Haider, William N Whiteley, James KennedyRichard Perry, Sekaran Lakshmanan, Annie Chakrabarti, Ahamad Hassan, Richard Marigold, Senthil Raghunathan, Don Sims, Mohit Bhandari, Ivan Wiggam, Khalid Rashed, Chris Douglass, ATTEST-2 Investigators

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1087-1096
Journal	The Lancet Neurology
Volume	23
Issue number	11
Early online date	16 Oct 2024
DOIs	https://doi.org/10.1016/S1474-4422(24)00377-6
Publication status	Published - 1 Nov 2024

Access to Document

10.1016/S1474-4422(24)00377-6

PIIS1474442224003776Final published version, 636 KBLicence: Creative Commons: Attribution (CC-BY)

https://linkinghub.elsevier.com/retrieve/pii/S1474442224003776

Cite this

Muir, K. W., Ford, G. A., Ford, I., Wardlaw, J. M., McConnachie, A., Greenlaw, N., Mair, G., Sprigg, N., Price, C. I., MacLeod, M. J., Dima, S., Venter, M., Zhang, L., O’brien, E., Sanyal, R., Reid, J., Sztriha, L. K., Haider, S., Whiteley, W. N., ... ATTEST-2 Investigators (2024). Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial. The Lancet Neurology, 23(11), 1087-1096. https://doi.org/10.1016/S1474-4422(24)00377-6

@article{3c1027461d4e43978776a04a310d9553,

title = "Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial",

author = "Muir, {Keith W} and Ford, {Gary A} and Ian Ford and Wardlaw, {Joanna M} and Alex McConnachie and Nicola Greenlaw and Grant Mair and Nikola Sprigg and Price, {Christopher I} and MacLeod, {Mary Joan} and Sofia Dima and Marius Venter and Liqun Zhang and Eoin O{\textquoteright}brien and Ranjan Sanyal and John Reid and Sztriha, {Laszlo k} and Syed Haider and Whiteley, {William N} and James Kennedy and Richard Perry and Sekaran Lakshmanan and Annie Chakrabarti and Ahamad Hassan and Richard Marigold and Senthil Raghunathan and Don Sims and Mohit Bhandari and Ivan Wiggam and Khalid Rashed and Chris Douglass and {ATTEST-2 Investigators}",

year = "2024",

month = nov,

day = "1",

doi = "10.1016/S1474-4422(24)00377-6",

language = "English",

volume = "23",

pages = "1087--1096",

journal = "The Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Science",

number = "11",

}

Muir, KW, Ford, GA, Ford, I, Wardlaw, JM, McConnachie, A, Greenlaw, N, Mair, G, Sprigg, N, Price, CI, MacLeod, MJ, Dima, S, Venter, M, Zhang, L, O’brien, E, Sanyal, R, Reid, J, Sztriha, LK, Haider, S, Whiteley, WN, Kennedy, J, Perry, R, Lakshmanan, S, Chakrabarti, A, Hassan, A, Marigold, R, Raghunathan, S, Sims, D, Bhandari, M, Wiggam, I, Rashed, K, Douglass, C & ATTEST-2 Investigators 2024, 'Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial', The Lancet Neurology, vol. 23, no. 11, pp. 1087-1096. https://doi.org/10.1016/S1474-4422(24)00377-6

TY - JOUR

T1 - Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial

AU - Muir, Keith W

AU - Ford, Gary A

AU - Ford, Ian

AU - Wardlaw, Joanna M

AU - McConnachie, Alex

AU - Greenlaw, Nicola

AU - Mair, Grant

AU - Sprigg, Nikola

AU - Price, Christopher I

AU - MacLeod, Mary Joan

AU - Dima, Sofia

AU - Venter, Marius

AU - Zhang, Liqun

AU - O’brien, Eoin

AU - Sanyal, Ranjan

AU - Reid, John

AU - Sztriha, Laszlo k

AU - Haider, Syed

AU - Whiteley, William N

AU - Kennedy, James

AU - Perry, Richard

AU - Lakshmanan, Sekaran

AU - Chakrabarti, Annie

AU - Hassan, Ahamad

AU - Marigold, Richard

AU - Raghunathan, Senthil

AU - Sims, Don

AU - Bhandari, Mohit

AU - Wiggam, Ivan

AU - Rashed, Khalid

AU - Douglass, Chris

AU - ATTEST-2 Investigators

PY - 2024/11/1

Y1 - 2024/11/1

U2 - 10.1016/S1474-4422(24)00377-6

DO - 10.1016/S1474-4422(24)00377-6

M3 - Article

SN - 1474-4422

VL - 23

SP - 1087

EP - 1096

JO - The Lancet Neurology

JF - The Lancet Neurology

IS - 11

ER -